Serum urate is the end-product of purine metabolism. Elevated serum urate is causal of 70 gout and a predictor of renal disease, cardiovascular disease and other metabolic 71 conditions. Genome-wide association studies (GWAS) have reported dozens of loci 72 associated with serum urate control, however there has been little progress in 73 understanding the molecular basis of the associated loci. Here we employed trans-74 ancestral meta-analysis using data from European and East Asian populations to 75 identify ten new loci for serum urate levels. Genome-wide colocalization with cis-76 expression quantitative trait loci (eQTL) identified a further five new loci. By cis-and 77 trans-eQTL colocalization analysis we identified 24 and 20 genes respectively where 78 the causal eQTL variant has a high likelihood that it is shared with the serum urate-79 associated locus. One new locus identified was SLC22A9 that encodes organic anion 80 transporter 7 (OAT7). We demonstrate that OAT7 is a very weak urate-butyrate 81 exchanger. Newly implicated genes identified in the eQTL analysis include those 82 encoding proteins that make up the dystrophin complex, a scaffold for signaling 83 proteins and transporters at the cell membrane; MLXIP that, with the previously 84 identified MLXIPL, is a transcription factor that may regulate serum urate via the 85 pentose-phosphate pathway; and MRPS7 and IDH2 that encode proteins necessary for 86 mitochondrial function. Trans-ancestral functional fine-mapping identified six loci 87 (RREB1, INHBC, HLF, UBE2Q2, SFMBT1, HNF4G) with colocalized eQTL that 88 contained putative causal SNPs (posterior probability of causality > 0.8). This 89 systematic analysis of serum urate GWAS loci has identified candidate causal genes at 90 19 loci and a network of previously unidentified genes likely involved in control of 91 serum urate levels, further illuminating the molecular mechanisms of urate control. 92 93 Author Summary 94 High serum urate is a prerequisite for gout and a risk factor for metabolic disease. 95
and S3). Of the ten new loci identified (seven from the trans-ancestral meta-analysis 170 and three in the East Asian-specific analysis), five mapped within an extended Chr11 171 locus (63.2-67.2Mb) that encompassed the previously identified SLC22A11, SLC22A12 172 and OVOL1 / RELA loci [4, 5] . In the East Asian GWAS, the peak marker falls outside 173 the RELA locus ( Figure S4 ). On closer inspection of the association signal from the 174 region within and surrounding the RELA locus it is clear that the causal variants in the 175 East Asian population are not the same as in the European population ( Figure S4 ). On 176 Chr6, given the association of the HLA-DQB1 locus with T-cell-mediated 177 autoimmunity [26] we also investigated if the lead HLA-DQB1 SNP (rs2858330) was 178 associated with other phenotypes using GWAS Central (www.gwascentral.org). There 179 were no reported associations at P < 0.001, indicating that the HLA-DQB1 signal in the 180 serum urate GWAS is distinct from the association of this region with autoimmunity. 181
The 35 loci found in Europeans explain 6.9% of variance in age and sex-adjusted serum 182 urate levels. In summary, a total of 38 loci associated with serum urate concentration 183 at a genome-wide level of significance were identified by this analysis. 
Conditional analysis identifies 8 additional variants associated with serum urate 222
Using the European summary statistics, a conditional and joint analysis was performed 223 with the objective of identifying independent genetic effects. Conditional and joint 224 analysis identified an additional four genome-wide significant associations at SLC2A9, 225 and one at each of ABCG2, TMEM171, SLC16A9 and SLC22A11/A12 (Table 1) . The 226 conditional analysis was limited to four independent associations at each locus, 227 therefore it remains possible that there are additional unidentified associations at these 228 loci. In a joint model these four loci explained an additional 0.54% of the variance of 229 age-and sex-adjusted serum urate levels (Table 1) . 230 231
Population-specific associations with serum urate levels 232
LocusZoom plots from each population were visually compared to the trans-ancestral 233 meta-analysis to identify population-specific and shared patterns of association. For 16 234 loci (ABCG2, B4GALT1, BCAS3, FGF5, BICC1, HFN4G, IGF1R, INHBB, NFAT5, 235 PDZK1, QRICH2, SLC16A9, SLC17A1, TMEM171, TRIM46, UBE2Q2) the pattern of 236 association was consistent between the East Asian and European GWAS suggesting 237 strong similarity between the underlying haplotypic structure and casual variant(s) 238 ( Figure S5 ). The MAF locus contains two association signals in the East Asian 239 population, one that is shared with the European population and one that is specific to 240 the East Asian population ( Figure S6) [12]. The lead SNP for the East Asian population 241 is rs889472; this variant is common in both European (C-allele = 0.38) and East Asian 242 (C-allele = 0.60) individuals from the 1000 Genomes Project yet there is no serum urate 243 association signal in the European population. Two other East Asian-specific signals 244 were identified on chromosome 11 near the SLC22A9 and PLA2G16 genes in addition 245 to the previously mentioned East Asian-specific signal at the RELA locus. These loci, 246 in combination with the conditionally independent and trans-ancestral associations, 247 mean that there are seven independent associations on chromosome 11 between 63.1Mb 248 and 67.3Mb. 249
250
Cis-eQTL colocalization analysis identifies 24 candidate causal genes at 19 serum 251 urate loci. 252
To connect the serum urate associations with the genes they influence, we utilised 253 publicly available expression data provided by the GTEx consortium and performed 254 colocalization with COLOC [27] ( Figure S7 and Table 2 ). This method attempts to 255 identify whether the causal variant is the same in both the eQTL and GWAS signal 256 indicating a putative causal mechanism, whereby the variant alters gene expression 257 (transcript levels) and expression influences the trait -in this case serum urate levels. 258
This approach provides further support for the loci identified by the trans-ancestral 259 meta-analysis by linking the serum urate signals into the biological process of gene 260 regulation. For 19 of the serum urate GWAS loci strong evidence for colocalization 261 (PPC > 0.8) was seen with 24 cis-eQTL (Table 2; Figure S7 To identify candidate causal genes that represent trans-eQTL, we pre-screened for 278 SNP-gene physical connectivity using the CoDeS3D algorithm and then tested for 279 colocalization with serum urate GWAS signals (Table 2) . This identified 20 trans-280 eQTL signals that co-localized (PPC > 0.8) with 15 GWAS loci ( Figure S7 ). Of the 20 281 genes with colocalized trans-eQTL we identified, only two had evidence within the 282 gene (P < 5 x 10 -04 ) for a signal of association with serum urate by GWAS ( Figure S8 
Testing for association with gout 313
To replicate the urate signals we tested the independent signals at eight existing loci, 314 ten new loci with genome-wide significance in the trans-ancestral meta-analysis and 315 five loci discovered by colocalization with eQTL (Table 1) FLRT1 and USP2 loci replicated (P £ 1.6 x 10 -03 ) in the European dataset in a 318 directionally-consistent fashion (i.e. the urate-increasing allele associated with an 319 increased risk of gout). The SLC22A9 and PLA2G16 loci replicated (P £ 0.013) in the 320 Japanese dataset also in a directionally-consistent fashion. All eight additional variants 321 identified in the European serum urate data set by conditional analysis (Table 1) Table S1 ). Functional partitioning 332 of serum urate SNP heritability according to cell type revealed significant enrichments 333 in the kidney (P = 3.2 x 10 -08 ), the gastrointestinal tract (P = 5.2 x 10 -08 ), and the liver 334 (P = 3.4 x 10 -03 ). A refined analysis of 218 functional annotations, which contribute to 335 the larger cell type groups, revealed 11 significant annotations: four histone marks in 336 the kidney H3K27ac (P = 1.2 x 10 -07 ), H3K9Ac (P = 1.5 x 10 -06 ), H3K4me3 (P = 9.6 x 337 10 -0.6 ), and H3K4me1 (P = 2.5 x 10 -05 ) and two histone marks in the gastrointestinal 338 tract -H3K27ac (P = 5.6 x 10 -06 ), and H3K4me1 (P = 4.8 x 10 -05 ). These histone marks 339 are characteristic of transcriptional activation and consistent with active expression of 340 nearby genes. 341 342
Trans-ancestral functional fine-mapping identifies putative causal variants 343
We sought to leverage both the functional enrichments and linkage disequilibrium 344 differences between the populations to identify candidate causal variants at each locus 345 associated with serum urate levels. To this end, we performed trans-ancestral fine-346 mapping with PAINTOR using the kidney, gastrointestinal tract, and liver cell type 3, S4). One of these urate-associated variants at SLC2A9, rs11723382, is also among 365 the maximally-associated cis-eQTL variants for RP11-448G15.1 (transformed 366 lymphocytes) (RP11-448G15.1 is a lncRNA located within the second intron of 367 SLC2A9) and disrupts two predicted motifs Hmx and Nkx2 ( Figure S10 and Table 3) (Table S4 ) and is amongst the maximally associated trans-eQTL variants for 387 DMD (encodes dystrophin). rs675209 at RREB1 is the maximal trans-eQTL variant for 388 UTRN (encodes utrophin), overlaps enhancer signatures in six tissues and alters 8 389 transcription factor binding motifs (Tables 3 and S4 ). The variants at HNF4G, SFMBT1, 390 UBE2Q2 and INHBC do not overlap putative regulatory elements (Table S4) . Although 391 rs13264750 (HNF4G), rs2115779 (SFBMT1) and rs9870898 (upstream of SFMBT1) 392 are predicted to change 8 binding motifs including HNF1 (Table 3) suggestive association in the trans-ancestral meta-analysis but the colocalization 418 analysis provided strong evidence that they participate in a causal pathway. Of these 419 five loci, we were able to replicate the association at DHRS9, MLXIP, MRPS7, RAI14 420 and IDH2 in gout, and for MLXIP we additionally replicated the association in the 421 Kanai et al. [6] data. Overall, the evidence that these five loci, identified solely by 422 colocalization of GWAS signal with an eQTL signal, have a true association with serum 423 urate is strong and provide empirical support for our genome-wide co-localization 424 approach using sub-genome wide significant GWAS signals. Overall, we identified 14 425 novel loci that we are confident are unlikely to represent false positive associations 426 (FGF5, B4GALT1, PLA2G16, SLC22A9, FLRT1, USP2, BICC1, DHRS9, An East Asian-specific genome-wide significant signal near the gene encoding OAT7, 520 SLC22A9, was confirmed. Ideally, we would have performed a colocalization analysis 521 to assess whether this genetic association may be influencing the expression of 522 SLC22A9. However, since SLC22A9 is specifically expressed in the liver and brain and 523 no East Asian eQTL are currently available for those tissues, this could not be 524 performed. In lieu of providing genetic evidence that this association influences the 525 expression of SLC22A9, we sought to evaluate whether OAT7 transported urate. Our 526 data suggest that OAT7 is a very weak urate transporter in the presence of the various 527 anions tested as exchangers (glutarate, a-ketoglutarate, butyrate, b-hydroxybutyrate). 528
It is possible that OAT7 may function as a more efficient urate transporter in the 529 presence of the appropriate (as yet unidentified) exchanging anion. OAT7 is a hepatic 530 transport protein that exchanges, for the short chain fatty acid butyrate, sulphyl 531 conjugates, xenobiotics and steroid hormones and is not inhibited by established 532 inhibitors and substrates of other organic anion transporters such as probenecid, 533 paraaminohippurate, nonsteroidal anti-inflammatory drugs and diuretics [36] . We 534 found that urate transport mediated by OAT7 is inhibited by the uricosuric drugs 535 benzbromarone and tranilast, which inhibit multiple other urate transporters [50] . Three 536 uncommon missense variants that influence the ability of OAT7 to transport pravastatin 537 by either causing the protein to be retained intracellularly or reducing protein levels at 538 the plasma membrane have been reported [51], all at a frequency < 1% in East Asian. 539
HNF4a plays a key role in the transactivation of the SLC22A9 promoter [51], an 540 interesting observation given that HNF4a is also required for expression of the gene 541 encoding the urate transportosome-stabilizing molecule PDZK1 in the liver [11], and 542 is implicated in control of serum urate levels via the MAFTRR locus [12] . 543 544
Colocalization analysis assigns causation to variants at MLXIPL and MLXIP 545
We identified the paralogs MLXIPL and MLXIP as the putative causal genes at the 546 Understanding the molecular mechanism of urate control by the MRPS7 and IDH2 loci 583 locus could lead to insights into the mitochondrial processes that influence serum urate 584 levels. 585 586
Trans-ancestral functional fine-mapping identifies putative causal variants 587
To connect GWAS loci where we identified candidate causal genes to an underlying 588 causal variant, we performed trans-ancestral fine-mapping with PAINTOR using the 589 kidney, gastrointestinal tract, and liver cell type group annotations as functional priors. 590
We identified six loci (RREB1, INHBC, HLF, UBE2Q2, SFMBT1, HNF4G ) that had 591 colocalized eQTL and contained SNPs with high posterior probabilities of causality 592 (>0.8). Two additional loci SLC2A9 and SLC22A12 also contained SNPs with high 593 posterior probabilities of causality (>0.8) that were cis and trans-eQTL for RP11-594 448G15.1 and RNF169, respectively. Many of these SNPs overlapped annotated 595 regulatory regions of the genome (Table 3) . These candidate causal variants and genes 596 provide a starting point for understanding how these variants alter serum urate levels. 597
The power of this approach is illustrated in our prior work on the PDZK1 locus [11] . 598
Here, we experimentally confirmed that PDZK1 was the causal gene, with rs1967017 599 (one of the two candidate causal variants identified with posterior probabilities >0.25 600 (Table S1 )) being a highly likely causal variant via altering a binding site for hepatocyte 601 nuclear factor 4a. We have also applied a similar approach to the MAF locus [12] . MAF 602 is a complex locus with population-specific signals, and for one of these signals we 603 experimentally demonstrated that the effect on urate arises from one of two SNPs 604 within a kidney specific enhancer that is co-expressed with MAF and HNF4A in the 605 developing proximal tubule. This study also identified colocalised eQTL for two long 606 This intercept adjusts the test statistics for confounding, such as cryptic relatedness, but 648 in contrast to genomic control will not remove inflation caused by a true polygenic 649 signal. 650 Independent regions were identified using the following protocol. Firstly, SNPs that 651 were genome-wide significant (P < 5 x 10 -08 ) were padded 50 kb either side of the SNP 652 position, and all overlapping regions were clumped together. Secondly, the maximal R 2 653 > 0.6 for the most significant SNP in each of these regions was calculated for each 654 population. Finally, the maximal regions from the P-value clumping and LD approach 655 were created, and any overlapping regions were merged. SNPs that were not present in 656 both datasets were also analyzed, and for those SNPs the LD was only calculated in the 657 relevant population. Based on their proximity to stronger signals four loci 658 (Chr4/rs114188639/CLNK1, Chr8/rs2927238/HNF4G, Chr11/rs641811/FLRT1, 659 Chr11/rs117595559/VPS51) were visually examined by LocusZoom and subjected to 660 conditional analysis -of these only rs641811 / FLRT1 was concluded to be independent 661 of the nearby signal. For all significant SNPs, the meta-analysis effect estimate was 662 calculated using the inverse variance method, and when there was no effect estimate, it 663 was estimated from the Z score using the following equation (1). 664 665
Equation 1 666 667
Conditional analysis 668 A conditional and joint analysis of the European summary statistics for all genome-669 wide significant regions identified by meta-analysis was done. This was not done on 670 the East Asian summary statistics owing to the lack of availability of both a LD matrix 671 and a reference haplotype set of sufficient size. For all imputed SNPs the effect estimate 672 was calculated as above (equation 1). The genotypic data from the UK Biobank was 673 used as the reference for the LD, and to improve computational efficiency only a 674 random 15% (22,872) of samples were included. Since the GCTA-COJO module [62] 675 was not designed to utilize dosage matrices, we performed this analysis using our own 676 software, Correlation-based Conditional analysis (COCO: 677 https://github.com/theboocock/coco) which, based on the methods presented in GCTA-678 COJO [62], was designed to perform conditional and joint analysis from summary 679 statistics with some minor alterations to use LD correlation matrices as input. To 680 discover conditional associations, the coco pipeline implemented a forward stepwise 681 selection using a residual-based regression. First, SNPs were ranked on marginal test 682 statistics, then the top SNP was selected and the result of extracting the residuals from 683 this model and performing a regression with every other SNP was estimated. These 684 test-statistics were then ranked. If the new top SNP passed the P-value threshold it was 685 added to a joint model with the other selected SNP, which was used as the new model 686 for residual extraction. This process was then repeated until no SNPs passed the 687 significance threshold. In practice, we restricted the maximum number of selected 688 SNPs at a locus to five (there is evidence for multiple signals at SLC2A9 [10]), and we 689 did not consider any pairs of SNPs having an R 2 > 0.9. To ensure that the method was 690 working correctly, simple phenotypes were simulated and it was verified that COCO 691 yields almost identical results to the lm function in the R programming language. 692 693 A mathematical explanation of the method is given as follows. We assume we have 694 mean centered genotypes in a matrix X. To perform GWAS we generate a marginal 695 statistic for each variant individually (Equation 2). 696 Where X1 is the genotype matrix of SNPs to be regressed on by the residuals, X2 is the 713 genotype matrix of the joint model, and N is equal to the number of SNPs in the residual 714 model. In practice the data matrix X is unavailable as summary statistics were used, but 715 it is possible to approximate this matrix using the LD structure from a reference panel 716 Where R is the reference genotype matrix, sigma is the LD matrix for the locus, and 722 the diagonal of R¢R is modified to be equal to the sample size of the SNP minus one in 723 
Cis-eQTL identification 796
We used COLOC [68] to colocalize the urate-associated loci with publicly available 797 eQTL data from the Genotype Tissue Expression Project (GTEx v6p). COLOC is a 798 Bayesian method that compares four different statistical models at a locus. These 799 models are: no causal variant in the GWAS or the eQTL region; a causal variant in 800 either the GWAS or the eQTL region, but not both; different causal variants in the 801 GWAS and the eQTL region; or a shared causal variant in the GWAS and the eQTL 802 region. All the cis-eQTL regions from a GTEx tissue were merged with the genome-803 wide European serum urate GWAS data. Genes that were annotated as novel transcripts 804 were removed. For learning the priors each cis-eQTL region was treated as independent 805 and the likelihood was maximized using the Nelder-mead algorithm. Genes that had a 806 posterior probability of colocalization greater than 0.8 were considered to have a shared 807 causal variant with serum urate. We did not restrict our analysis only to the genome-808 wide significant loci, which made it possible to identify novel serum urate loci. If 809 multiple tissues supported colocalization at probability > 0.8 the posterior probability 810 was averaged. 811 were subjected to partial ovariectomy under tricane (SIGMA St Louis, MO) anesthesia 871 (0.17% for 15-20 min) as described previously [50] . A small incision was made in the 872 abdomen and a lobe of ovary was removed. Subsequently, the oocytes were pre-washed 873 for 20 min in Ca 2+ -free ND96 medium (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM 874 HEPES, pH 7.4) to remove blood and damaged tissue. Oocytes were then defolliculated 875 by treatment with 3.5 mg/ml of collagenase enzyme (Roche, Indianapolis, IN) in Ca 2+ -876 free ND96 medium for about 120 min with gentle agitation at room temperature (25°C). 877 Subsequent to this treatment, oocytes were washed three times with ND96 medium, 878 and incubated (16-18 °C) in isotonic Ca 2+ -containing ND96 medium (96 mM NaCl, 2.0 879 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2 and 5 mM Hepes, pH 7.4) supplemented with 880 2.5 mM pyruvate and gentamycin (10 µg/ml). 881 882 For expression of OAT7 and OAT1 in Xenopus laevis oocytes, their respective full-883 length cDNAs were cloned into the pGEMHE vector, wherein the cDNA insert is 884 flanked by the Xenopus laevis b-globin 5′-UTR and 3′-UTR [73]. These constructs were 885 linearized and cRNAs were synthesized in vitro using T7 RNA polymerase 886 (mMESSAGE mMACHINE; Ambion, Austin, TX) following the supplier's protocol. 887
Isopropanol-precipitated, in vitro transcribed capped cRNAs were washed twice with 888 70% ethanol, the cRNA pellet was dried and then dissolved in sterile nuclease-free 889 water. The yield and integrity of the capped cRNA samples was assessed by 890 spectroscopy (at 260 nm) and 1% agarose-formaldehyde gel electrophoresis 891 respectively. All cRNA samples were stored frozen in aliquots at -80 °C until used. approximately 60 min of starvation, oocytes were preincubated in the ND96 uptake 908 medium for 30 min before incubation (25 o C, in a horizontal shaker-incubator) in the 909 uptake medium containing [ 14 C]-urate (40 µM). After 60 min of incubation in the 910 uptake medium, oocytes (20 per group) were washed three times with ice-cold uptake 911 medium to remove external adhering radioisotope. OAT7-expressing oocytes were then 912 exposed to DMSO (diluent for uricosurics) or the uricosuric drugs tranilast and 913 benzbromarone, as indicated. The radioisotope content of each individual oocyte was 914 measured by scintillation counter following solubilization in 0. transporter. Xenopus oocytes were microinjected with water (control cells) or cRNA 950 for OAT1 or OAT7. OAT7-expressing cells have a very modest urate transport activity 951 that is increased by prior microinjection with butyrate, to "trans-activate" urate-butyrate 952 exchange. This transport activity is inhibited by the uricosurics tranilast and 953 benzbromarone, each at a concentration of 100 µM; DMSO, the diluent for tranilast 954 and benzbromarone, has no effect on urate transport. * refers to P<0.001 compared to 955 OAT7-expressing cells without butyrate pre-injection and water control cells. Data 956 shown are from a single representative experiment. 957
